Latest / Science News Today | 2 Min News | The Daily News Now!
Fluvoxamine Offers Hope for Long COVID Fatigue | Science News
A breakthrough for long COVID sufferers: fluvoxamine, a common antidepressant, has shown remarkable promise in slashing debilitating fatigue and boosting quality of life in a global trial. With a 99% chance of outperforming placebo, this widely available drug could offer real relief where few treatments exist — and its adaptive trial design may speed up access for those desperately in need. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.